A family with Andersen-Tawil syndrome and dilated cardiomyopathy

Heart Rhythm

Volumn 3, Issue 11, 2006, Pages 1346-1350

  Schoonderwoerd, Bas A ^a   Wiesfeld, Ans C P ^a   Wilde, Arthur A M ^b   van den Heuvel, Freek ^a   Van Tintelen, J Peter ^a   van den Berg, Maarten P ^a   Van Veldhuisen, Dirk J ^a   Van Gelder, Isabelle C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Andersen Tawil syndrome; Cardiomyopathy; KCNJ2; Ventricular fibrillation

Indexed keywords

LISINOPRIL; METOPROLOL; NICORANDIL; SALBUTAMOL;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ANAMNESIS; ANDERSEN SYNDROME; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; HEART ARREST; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANDERSEN SYNDROME; BIOPSY; CARDIOMYOPATHY, DILATED; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MUTATION, MISSENSE; PEDIGREE; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 33750298629     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.07.021     Document Type: Article

References (33)

1. Andersen E.D., Krasilnikoff P.A., and Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?. Acta Paediatr Scand 60 (1971) 559-564
2. Tawil R., Ptacek L.J., Pavlakis S.G., DeVivo D.C., Penn A.S., Ozdemir C., and Griggs R.C. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 35 (1994) 326-330
3. Zhang L., Benson D.W., Tristani-Firouzi M., Ptacek L.J., Tawil R., Schwartz P.J., George A.L., Horie M., Andelfinger G., Snow G.L., Fu Y.H., Ackerman M.J., and Vincent G.M. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 111 (2005) 2720-2726
4. Yoon G., Oberoi S., Tristani-Firouzi M., Etheridge S.P., Quitania L., Kramer J.H., Miller B.L., Fu Y.H., and Ptacek L.J. Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype. Am J Med Genet A 140 (2006) 312-321
5. Plaster N.M., Tawil R., Tristani-Firouzi M., Canun S., Bendahhou S., Tsunoda A., Donaldson M.R., Iannaccone S.T., Brunt E., Barohn R., Clark J., Deymeer F., George Jr. A.L., Fish F.A., Hahn A., Nitu A., Ozdemir C., Serdaroglu P., Subramony S.H., Wolfe G., Fu Y.H., and Ptacek L.J. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 (2001) 511-509
6. Tristani-Firouzi M., Jensen J.L., Donaldson M.R., Sansone V., Meola G., Hahn A., Bendahhou S., Kwiecinski H., Fidzianska A., Plaster N., Fu Y.H., Ptacek L.J., and Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110 (2002) 381-388
7. Andelfinger G., Tapper A.R., Welch R.C., Vanoye C.G., George Jr. A.L., and Benson D.W. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71 (2002) 663-668
8. Chun T.U., Epstein M.R., Dick M., Andelfinger G., Ballester L., Vanoye C.G., George Jr. A.L., and Benson D.W. Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm 1 (2004) 235-241
9. Lopes C.M., Zhang H., Rohacs T., Jin T., Yang J., and Logothetis D.E. Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 34 (2002) 933-944
10. Takemoto M., Yoshimura H., Ohba Y., Matsumoto Y., Yamamoto U., Mohri M., Yamamoto H., and Origuchi H. Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. J Am Coll Cardiol 45 (2005) 1259-1265
11. Davies N.P., Imbrici P., Fialho D., Herd C., Bilsland L.G., Weber A., Mueller R., Hilton-Jones D., Ealing J., Boothman B.R., Giunti P., Parsons L.M., Thomas M., Manzur A.Y., Jurkat-Rott K., Lehmann-Horn F., Chinnery P.F., Rose M., Kullmann D.M., and Hanna M.G. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology 65 (2005) 1083-1089
12. Lucet V., Lupoglazoff J.M., and Fontaine B. Andersen syndrome, ventricular arrhythmias and channelopathy (a case report). Arch Pediatr 9 (2002) 1256-1259
13. Fodstad H., Swan H., Auberson M., Gautschi I., Loffing J., Schild L., and Kontula K. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome. J Mol Cell Cardiol 37 (2004) 593-602
14. Kannankeril P.J., Roden D.M., and Fish F.A. Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndrome. J Cardiovasc Electrophysiol 15 (2004) 119
15. Beuckelmann D.J., Nabauer M., and Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73 (1993) 379-385
16. Koumi S., Backer C.L., and Arentzen C.E. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation (1995) 92164-92174
17. Bezzina C.R., Rook M.B., Groenewegen W.A., Herfst L.J., van der Wal A.C., Lam J., Jongsma H.J., Wilde A.A., and Mannens M.M. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 92 (2003) 159-168
18. Olson T.M., Michels V.V., Ballew J.D., Reyna S.P., Karst M.L., Herron K.J., Horton S.C., Rodeheffer R.J., and Anderson J.L. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293 (2005) 447-454
19. Royer A., van Veen T.A., Le B.S., Marionneau C., Griol-Charhbili V., Leoni A.L., Steenman M., van Rijen H.V., Demolombe S., Goddard C.A., Richer C., Escoubet B., Jarry-Guichard T., Colledge W.H., Gros D., de Bakker J.M., Grace A.A., Escande D., and Charpentier F. Mouse model of SCN5A-linked hereditary Lenegre's disease: age-related conduction slowing and myocardial fibrosis. Circulation 111 (2005) 1738-1746
20. Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M., Atherton J., Vidaillet Jr. H.J., Spudich S., De G.U., Seidman J.G., Seidman C., Muntoni F., Muehle G., Johnson W., and McDonough B. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341 (1999) 1715-1724
21. Taylor M.R., Fain P.R., Sinagra G., Robinson M.L., Robertson A.D., Carniel E., Di L.A., Bohlmeyer T.J., Ferguson D.A., Brodsky G.L., Boucek M.M., Lascor J., Moss A.C., Li W.L., Stetler G.L., Muntoni F., Bristow M.R., and Mestroni L. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41 (2003) 771-780
22. Schmitt J.P., Kamisago M., Asahi M., Li G.H., Ahmad F., Mende U., Kranias E.G., MacLennan D.H., Seidman J.G., and Seidman C.E. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299 (2003) 1410-1413
23. Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F., Larderet G., Brahmbhatt B., Brown K., Bauce B., Muriago M., Basso C., Thiene G., Danieli G.A., and Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
24. Whyte K.F., Addis G.J., Whitesmith R., and Reid J.L. The mechanism of salbutamol-induced hypokalaemia. Br J Clin Pharmacol 23 (1987) 65-71
25. Takahashi T., Tandai S., Toki T., Sato T., Eto S., Sato A., Ueda T., Sato S., Ichinose K., Ito E., and Yonesaka S. KCNJ2 mutation in intractable ventricular arrhythmia with Andersen's syndrome. Pediatr Int 47 (2005) 220-223
26. Ai T., Fujiwara Y., Tsuji K., Otani H., Nakano S., Kubo Y., and Horie M. Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. Circulation 105 (2002) 2592-2594
27. Canun S., Perez N., and Beirana L.G. Andersen syndrome autosomal dominant in three generations. Am J Med Genet 85 (1999) 147-156
28. Katz J.S., Wolfe G.I., Iannaccone S., Bryan W.W., and Barohn R.J. The exercise test in Andersen syndrome. Arch Neurol 56 (1999) 352-356
29. Junker J., Haverkamp W., Schulze-Bahr E., Eckardt L., Paulus W., and Kiefer R. Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. Neurology 59 (2002) 466
30. Yang Z., Shi G., Li C., Wang H., Liu K., and Liu Y. Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model. J Cardiovasc Electrophysiol 15 (2004) 815-820
31. Watanabe O., Okumura T., Takeda H., Nakamura W., Segawa K., Ito H., and Yoshimoto N. Nicorandil, a potassium channel opener, abolished torsades de pointes in a patient with complete atrioventricular block. Pacing Clin Electrophysiol 22 (1999) 686-688
32. Fujimoto Y., Morita H., Fukushima K.K., and Ohe T. Nicorandil abolished repolarisation alternans in a patient with idiopathic long QT syndrome. Heart 82 (1999) e8
33. Tawil R., McDermott M.P., Brown Jr. R., Shapiro B.C., Ptacek L.J., McManis P.G., Dalakas M.C., Spector S.A., Mendell J.R., Hahn A.F., Griggs R.C., and Working Group on Periodic Paralysis. Randomized trials of dichlorphenamide in the periodic paralyses. Ann Neurol 47 (2000) 46-53